Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Valirx Share Price (VAL)



Share Price Information for Valirx (VAL)


Share Price: 5.50Bid: 5.25Ask: 5.75Change: 0.00 (0.00%)No Movement on Valirx
Spread: 0.50Spread as %: 9.52%Open: 5.00High: 5.875Low: 4.375Yesterday’s Close: 5.50

Valirx Plc Ord 0.1P

Valirx is listed in the FTSE AIM All-Share
Valirx is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
5.50

Share Price SpacerBid
5.25

Share Price SpacerAsk
5.75

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
31,975,269

Share Price SpacerOpen
5.00

Share Price SpacerHigh
5.875

Share Price SpacerLow
4.375

Share Price SpacerClose
5.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 263.41m £14.49m 30,000

52 Week High 7.73 52 Week High Date 12-DEC-2017
52 Week Low 0.90 52 Week Low Date 20-NOV-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
633 12,230,554 11,143,614 -0.644 -8.54 0.00 0.00


London South East Users info for Valirx




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

15-Dec-17
15:44:11
5.35
179,954
Sell* 
5.25
5.75
9,628
Trade Type:
Ordinary
Delayed publication

15-Dec-17
16:29:20
5.625
71,004
Buy* 
5.25
5.75
3,994
Trade Type:
Ordinary

15-Dec-17
16:28:42
5.515
136,102
Sell* 
5.50
5.75
7,506
Trade Type:
Ordinary




View more Valirx trades >>

Directors Deals for Valirx (VAL)
Trade DateActionNotifierPriceCurrencyAmountHolding
15-Mar-17Placing
Trade Notifier Information for Valirx
Satu Vainikka held the position of CEO at Valirx at the time of this trade.
 Satu Vainikka
2.5GBX400,0001024909
15-Mar-17Placing
Trade Notifier Information for Valirx
Gerald Desler held the position of CFO at Valirx at the time of this trade.
 Gerald Desler
2.5GBX400,000941875
15-Mar-17Placing
Trade Notifier Information for Valirx
George Morris held the position of Non-Executive Director at Valirx at the time of this trade.
 George Morris
2.5GBX400,000988287
View more Valirx directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 19:43TheDogHouserRE: Inanaco5.50No Opinion
Inanaco is a douche bag - filter them
Today 19:40MisterPositiveRE: 17p in the morning?5.50Strong Buy
Unfortunately their planned attack looks to have back fired.

For me VAL is now a conviction Buy and will be topping up tomorrow ahead of YES vote on Thursday.

GLA
Today 19:36tozerkRE: Inanaco5.50No Opinion
He'll be back with a different profile thats all.
Today 19:35MisterPositiveRE: Inanaco5.50No Opinion
You might be Off for a very long time mate.
Today 19:27nomlungu17p in the morning?5.50No Opinion
I have some sell.
Today 19:16GentlemanRogueRE: Inanaco5.50No Opinion
Inanaco, you posted earlier.

"RE: InanacoToday 18:20 does Dr. Suzy Dilly work for VAL ... ? thought it was a separate private Ltd company, which is 60% owned by VAL"

Yes, she does work for ValiRX as I posted:

"RE: InanacoToday 18:57Dr Suzy Dilly is the Chief Science Officer for ValiRX and ceo of Valiseek"

Now you're insinuating that because she's not a director has any bearing on the matter...fed up of your constant posting to clog up this bb to bury relevant… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Valirx (VAL) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.